...
首页> 外文期刊>Asian Journal of Pharmaceutical Sciences >Targeted delivery of docetaxel to the metastatic lymph nodes: A comparison study between nanoliposomes and activated carbon nanoparticles
【24h】

Targeted delivery of docetaxel to the metastatic lymph nodes: A comparison study between nanoliposomes and activated carbon nanoparticles

机译:多西他赛靶向转移至淋巴结转移:纳米脂质体与活性炭纳米颗粒的比较研究

获取原文
           

摘要

Abstract The objective of this study is to compare the targeting ability of activated carbon nanoparticles and nanoliposomes, which are used as carriers for delivering docetaxel (DTX) to the metastatic lymph nodes. In this study, we first prepared the DTX-loaded activated carbon nanoparticles (DTX-AC-NPs) by modifying the activated carbon with nitric acid oxidation and absorbing {DTX} in the concentrated nitro-oxide nanocarbon. We then prepared DTX-loaded nanoliposomes (DTX-LPs) by the proliposome method. The physiochemical properties of DTX-AC-NPs and DTX-LPs were carefully evaluated in?vitro. The metastatic lymph node uptake and the injection site retention were investigated by analyzing the {DTX} concentration in metastatic lymph nodes and injection sites. The result showed that DTX-AC-NPs and DTX-LPs with suitable and stable physicochemical properties could be used for in?vivo lymph node targeting studies. DTX-AC-NPs significantly increased DTX-AUC(0–24) and prolonged DTX-retention in metastatic lymph nodes compared to DTX-LPs and non-modified activate carbon in?vivo. This study demonstrated activated carbon nanoparticles may be potential intralymphatic drug delivery system to preferentially target regional metastatic lymph nodes.
机译:摘要这项研究的目的是比较活性炭纳米颗粒和纳米脂质体的靶向能力,所述活性炭纳米颗粒和纳米脂质体被用作将多西他赛(DTX)递送至转移性淋巴结的载体。在这项研究中,我们首先通过用硝酸氧化修饰活性炭并在浓氮氧化物纳米碳中吸收 {DTX }来制备载有DTX的活性炭纳米颗粒(DTX-AC-NPs)。然后,我们通过前脂质体方法制备了载有DTX的纳米脂质体(DTX-LP)。体外仔细评估了DTX-AC-NP和DTX-LP的理化特性。通过分析转移性淋巴结和注射部位中的 {DTX }浓度来研究转移性淋巴结的摄取和注射部位的保留。结果表明,具有合适且稳定的理化性质的DTX-AC-NP和DTX-LP可用于体内淋巴结靶向研究。与DTX-LP和未经修饰的体内活性炭相比,DTX-AC-NPs显着增加了DTX-AUC(0-24)并延长了转移淋巴结中DTX的保留时间。这项研究表明,活性炭纳米颗粒可能是潜在地优先靶向区域转移性淋巴结的潜在的淋巴内药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号